Bioventus Affirms FY2025 Adj EPS Guidance of $0.64-$0.68 vs $0.66 Est; Affirms FY2025 Sales Guidance of $560.00M-$570.00M vs $564.87M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Bioventus (NASDAQ:BVS) affirms FY2025 Adj EPS guidance from $0.64-$0.68 to $0.64-$0.68 vs $0.66 analyst estimate. Affirms FY2025 sales outlook from $560.00 million-$570.00 million to $560.00 million-$570.00 million vs
Bioventus (NASDAQ:BVS) affirms FY2025 Adj EPS guidance from $0.64-$0.68 to $0.64-$0.68 vs $0.66 analyst estimate. Affirms FY2025 sales outlook from $560.00 million-$570.00 million to $560.00 million-$570.00 million vs $564.87 million estimate.